| Patents for C07K - Peptides (3,738) |
|---|
| 05/06/2004 | EP0889955B1 Recombinant phages |
| 05/06/2004 | CA2503027A1 Thymidylate synthase polymorphisms for use in screening for cancer susceptibility |
| 05/06/2004 | CA2482744A1 Hiv envelope-cd4 complexes and hybrids |
| 05/05/2004 | CN1494552A Flt 4 (VEGFR-3) as target for tumor imaging and anti-tumor therapy |
| 05/04/2004 | CA2296178C Human intestinal npt2b |
| 04/29/2004 | WO2004034957A2 Methods for treatment of helicobacter pylori-associated disorders |
| 04/29/2004 | WO2004014311A3 Nogo receptor antagonists |
| 04/29/2004 | WO2003048187A3 Peptides and use thereof in therapeutic agents against hiv infection |
| 04/29/2004 | WO2002066056A8 Synthetic vaccines comprising polyhydroxypolymer carriers |
| 04/29/2004 | US20040082514 Methods for treatment of helicobacter pylori-associated disorders |
| 04/29/2004 | US20040081662 Vaccine |
| 04/29/2004 | CA2503325A1 Methods for treatment of helicobacter pylori-associated disorders |
| 04/28/2004 | EP1413297A1 Cyclosporin-containing soft capsule preparations |
| 04/22/2004 | WO2004033485A2 Nucleic acid supported protein complementation |
| 04/22/2004 | WO2004033483A2 Liposomal system and method of using same |
| 04/22/2004 | WO2003051272A9 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR GnRH-I AND GnRH-II MODULATION OF T-CELL ACTIVITY, ADHESION, MIGRATION AND EXTRAVASATION |
| 04/22/2004 | WO2003014308A9 Cysteine mutants and methods for detecting ligand binding to biological molecules |
| 04/22/2004 | US20040076607 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 04/21/2004 | EP1409547A2 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer |
| 04/21/2004 | CN1146432C Cell growth regulator |
| 04/15/2004 | WO2004031210A2 Optimized multi-epitope constructs and uses thereof |
| 04/15/2004 | US20040072236 PrPSc -interacting molecules and uses thereof |
| 04/15/2004 | US20040072188 Comprises nucleotide sequences coding B-cell activating factor receptor (BAFF-R) for diagnosis, prevention, treatment and/or delay of cancers, lymphomas and autoimmune diseases |
| 04/15/2004 | US20040071712 Modified peptides as therapeutic agents |
| 04/15/2004 | CA2500955A1 Optimized multi-epitope constructs and uses thereof |
| 04/08/2004 | WO2004029072A2 PrPsc -INTERACTING MOLECULES AND USES THEREOF |
| 04/08/2004 | WO2004029070A2 Methods for blocking adipocyte differentiation and triglyceride accumulation with dual-specificity tyrosine- (y) - phosphorylation regulated kinase 4 (dyrk4) inhibitors |
| 04/08/2004 | WO2004028473A2 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/08/2004 | CA2500120A1 Prpsc -interacting molecules and uses thereof |
| 04/08/2004 | CA2498483A1 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/07/2004 | CN1144817C Novel human 'beta' 2 integrin 'alpha' sub unit |
| 04/01/2004 | WO2003060090A3 Novel cytokine zcytor17 ligand |
| 03/31/2004 | EP0784677B1 Inhibitor of stem cell proliferation and uses thereof |
| 03/30/2004 | US6713270 Dna encoding a novel steroid receptor is introduced into cell with reporter gene, potential ligand is incubated with cell, production of reporter protein means ligand binds receptor |
| 03/25/2004 | WO2004024749A2 Thermostable reverse transcriptases and uses thereof |
| 03/25/2004 | WO2003015812A3 Beta-amyloid-analogue-t-cell epitop vaccine |
| 03/25/2004 | US20040058394 Humanized anti-LT-beta-R antibodies |
| 03/25/2004 | US20040057953 Modified peptides as therapeutic agents |
| 03/25/2004 | US20040057950 Overexpression of which can lead to tumorigenesis; useful in treatment of tumors of breast, lung, colon, kidney, bladder, head and neck, ovary, prostate, and brain |
| 03/18/2004 | WO2004022579A2 Cellular delivery of natriuretic peptides |
| 03/18/2004 | WO2004022578A2 Methods, compositions and libraries pertaining pna dimer and pna oligomer synthesis |
| 03/18/2004 | WO2003051272A3 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR GnRH-I AND GnRH-II MODULATION OF T-CELL ACTIVITY, ADHESION, MIGRATION AND EXTRAVASATION |
| 03/18/2004 | WO2003014308A3 Cysteine mutants and methods for detecting ligand binding to biological molecules |
| 03/18/2004 | US20040053845 Modified peptides as therapeutic agents |
| 03/18/2004 | US20040053324 Assays and compositions for identifying agents that modulate the activity of deubiquitinating agents |
| 03/18/2004 | CA2495895A1 Methods, compositions and libraries pertaining pna dimer and pna oligomer synthesis |
| 03/11/2004 | WO2004020458A2 Assays and compositions for identifying agents that modulate the activity of deubiquitinating agents |
| 03/09/2004 | US6703365 Glucagon-like insulinotropic peptides, compositions and methods |
| 03/04/2004 | WO2002012502A9 Anti-tnf antibodies, compositions, methods and uses |
| 03/04/2004 | US20040044188 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases |
| 03/04/2004 | US20040043418 Humanized antibodies that sequester Abeta peptide |
| 03/03/2004 | EP1394179A1 Process for producing erythropoietin free from animal proteins |
| 03/03/2004 | EP1394175A1 Inhibitors of interleukin-1beta converting enzyme |
| 03/03/2004 | EP1393750A2 Conjugates for treating an immune disease |
| 02/26/2004 | WO2004016644A2 Compositions and methods used for identifying factors required for the agglomeration of proteins |
| 02/26/2004 | WO2004016642A2 ISOFORM SPECIFIC INTERACTIONS OF APOLIPOPROTEIN E TO AN INTERMEDIATE CONFORMATION OF ALZHEIMER Aβ PEPTIDE |
| 02/26/2004 | US20040038902 For therapy of neoplastic disease |
| 02/26/2004 | US20040037829 For immunoregulation and/or treatment of inflammation; muteins |
| 02/25/2004 | CN1477970A 疫苗 Vaccine |
| 02/25/2004 | CN1477968A Methods for treating rheumatic diseases using soluble CTLA4 molecule |
| 02/19/2004 | WO2004014938A2 Thrombopoiesis-stimulating proteins having reduced immunogenicity |
| 02/19/2004 | WO2004014937A2 Thrombin peptide derivatives |
| 02/19/2004 | WO2004014311A2 Nogo receptor antagonists |
| 02/19/2004 | CA2495121A1 Nogo receptor antagonists |
| 02/19/2004 | CA2491052A1 Thrombin peptide derivatives |
| 02/18/2004 | CN1138786C Antibody for identifying osteoclast forming inhibitor binding protein, and preparing process and use |
| 02/12/2004 | WO2004013160A2 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof |
| 02/12/2004 | CA2495478A1 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof |
| 02/05/2004 | WO2004011485A2 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 02/05/2004 | US20040023307 DNA encoding a novel RG1 polypeptide |
| 02/05/2004 | CA2493306A1 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 01/29/2004 | WO2004009776A2 TREATMENT OF TNFα RELATED DISORDERS |
| 01/29/2004 | WO2004009616A2 Ghrelin analogs |
| 01/29/2004 | WO2003048184A3 Flavivirus ns1 subunit vaccine |
| 01/29/2004 | US20040018981 Glucagon-like peptide-1 (glp-1) receptor agonist |
| 01/29/2004 | US20040018558 Method for identifying modulators of G protein coupled receptor signaling |
| 01/29/2004 | CA2803741A1 Treatment of psoriasis with human anti-tnf alpha antibody |
| 01/29/2004 | CA2493067A1 Treatment of tnf.alpha. related disorders |
| 01/29/2004 | CA2491946A1 Ghrelin analogs |
| 01/28/2004 | EP1384488A2 Method and kit for imaging organs and tissues, using labelled antibodies |
| 01/27/2004 | US6682902 Human extracellular matrix polypeptides; polynucleotides; expression vectors; host cells; medical diagnosis; prostate cancer; detection of metastasis |
| 01/21/2004 | EP1382611A2 Bacillus strains and Pesticidal proteins |
| 01/21/2004 | EP0830376B1 Process for producing erythropoietin containing no animal proteins |
| 01/21/2004 | CN1469883A Peptide selection method |
| 01/20/2004 | US6680368 Protein encoded by dna |
| 01/14/2004 | CN1468308A Anti-tnf antibodies, compositions, methods and uses |
| 01/08/2004 | US20040005318 Method of treatment using human sequence antibodies against human CTLA-4. In particular, methods of treating cancer are provided. |
| 01/02/2004 | EP1375519A2 Method for affecting cellular function using antibodies |
| 01/02/2004 | EP1372696A2 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 01/01/2004 | US20040002109 Process for identifying modulators of G-protein-coupled receptors |
| 12/31/2003 | WO2004000872A2 Improved alphavirus vectors having attenuated virion structural proteins |
| 12/31/2003 | WO2004000366A1 Pegylated factor vii glycoforms |
| 12/31/2003 | CA2490360A1 Pegylated factor vii glycoforms |
| 12/18/2003 | WO2003104262A2 Gp41 peptides and methods based-thereon for inhibiting hiv fusion to target cells |
| 12/18/2003 | WO2003084995A3 Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof |
| 12/18/2003 | CA2489050A1 Gp41 peptides and methods based-thereon for inhibiting hiv fusion to target cells |
| 12/17/2003 | EP1370575A2 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 12/17/2003 | EP1370276A2 Medical uses of intercellular communication facilitating compounds |
| 12/17/2003 | EP0792363B1 Novel pesticidal proteins and strains |
| 12/17/2003 | CN1462276A Peptide-based compounds |